Company News for February 9, 2010 - Corporate Summary
• Biogen Idec (NASDAQ:BIIB) posted better-than-estimated fourth quarter results of $1.20, beating Zacks estimates of $1.05, on inline revenues of $1.1 billion. The company said it sees full year earnings of $4.50 a share
• International Flavors and Fragrances (NYSE:IFF) reported fourth quarter results of 63 cents, three cents better than Zacks estimates, on sales of $586 million, versus Zacks estimates of $572 million
• Molson Coors (NYSE:TAP) released fourth quarter results of $1.02, below Zacks estimates of $1.09
• Coventry Health (NYSE:CVH) announced fourth quarter earnings of 74 cents, above Zacks estimates of 56 cents, on inline revenues of $3.4 billion
• NYSE Euronext (NYSE:NYX) reported better-than-expected results of 58 cents, versus Zacks estimates of 48 cent estimates on revenues of 640 million, versus Zacks estimates of $637 million
• Bernstein upgraded Verizon (NYSE:VZ) to "overweight"
• Bank of America (NYSE:BAC) upgraded Monsanto (NYSE:MON) to "buy" with a price target of $96
• SAP (NYSE:SAP) was upgraded from "underweight" to "market weight" by analysts at FBR, with a price target of $44
• Royal Dutch Shell (NYSE:RDS) received an upgrade from "underweight" to "overweight" by analysts at HSBC (NYSE:HBC)
The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
